Interactions and release of two palmitoyl peptides from phytantriol cubosomes

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 117, Issue , 2017, Pages 60-67

  Akhlaghi, Seyedeh Parinaz ^a   Loh, Watson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cubosomes; In vitro release; Palmitoyl peptides; Phytantriol; SAXS

Indexed keywords

ALCOHOL DERIVATIVE; CUBOSOME; DRUG CARRIER; PALMITIC ACID DERIVATIVE; PEPTIDE; PHYTANTRIOL; UNCLASSIFIED DRUG; 2 HYDROXYPROPYL BETA CYCLODEXTRIN; 3,7,11,15-TETRAMETHYL-1,2,3-HEXADECANETRIOL; FATTY ALCOHOL; LIPOPEPTIDE; MINOXIDIL; NANOPARTICLE;

AQUEOUS SOLUTION; ARTICLE; CRYOELECTRON MICROSCOPY; DIALYSIS; DRUG INTERACTION; DRUG STABILITY; IN VITRO STUDY; ISOTHERMAL TITRATION CALORIMETRY; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LOW TEMPERATURE; PHOTON CORRELATION SPECTROSCOPY; ROOM TEMPERATURE; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; X RAY CRYSTALLOGRAPHY; ZETA POTENTIAL; CHEMISTRY; DRUG RELEASE; METABOLISM; PROCEDURES; SMALL ANGLE SCATTERING; X RAY DIFFRACTION;

2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; DRUG INTERACTIONS; DRUG LIBERATION; FATTY ALCOHOLS; LIPOPEPTIDES; MINOXIDIL; NANOPARTICLES; SCATTERING, SMALL ANGLE; X-RAY DIFFRACTION;

EID: 85017130976     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2017.03.022     Document Type: Article

References (32)

1. [1] Spicer, P.T., Hayden, K.L., Lynch, M.L., Ofori-Boateng, A., Burns, J.L., Novel process for producing cubic liquid crystalline nanoparticles (cubosomes). Langmuir 17 (2001), 5748–5756, 10.1021/la010161w.
2. [2] Barauskas, J., Landh, T., Phase behavior of the phytantriol/water system. Langmuir 19 (2003), 9562–9565, 10.1021/la0350812.
3. [3] Rattanapak, T., Young, K., Rades, T., Hook, S., Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration. J. Pharm. Pharmacol. 64 (2012), 1560–1569, 10.1111/j.2042-7158.2012.01535.x.
4. [4] Richert, S., Schrader, A., Schrader, K., Transdermal delivery of two antioxidants from different cosmetic formulations. Int. J. Cosmet. Sci. 25 (2003), 5–13, 10.1046/j.1467-2494.2003.00158.x.
5. [5] Rizwan, S.B., Hanley, T., Boyd, B.J., Rades, T., Hook, S., Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling and release kinetics. J. Pharm. Sci. 98 (2009), 4191–4204, 10.1002/jps.21724.
6. [6] Dong, Y., Larson, I., Hanley, T., Boyd, B.J., Bulk and dispersed aqueous phase behavior of phytantriol: effect of Vitamin E acetate and F127 polymer on liquid crystal nanostructure. Langmuir 22 (2006), 9512–9518, 10.1021/la061706v M.U. V, V. Park.
7. [7] Rizwan, S.B., Dong, Y.-D., Boyd, B.J., Rades, T., Hook, S., Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Micron 38 (2007), 478–485, 10.1016/j.micron.2006.08.003.
8. [8] Akhlaghi, S.P., Ribeiro, I.R., Boyd, B.J., Loh, W., Impact of preparation method and variables on the internal structure, morphology, and presence of liposomes in phytantriol-Pluronic® F127 Cubosomes. Colloids Surf. B Biointerfaces 145 (2016), 845–853, 10.1016/j.colsurfb.2016.05.091.
9. [9] Lupo, M.P., Cole, A.L., Cosmeceutical peptides. Dermatol. Ther. 20 (2007), 343–349, 10.1111/j.1529-8019.2007.00148.x.
10. [10] Hamley, I.W., Lipopeptides: from self-assembly to bioactivity. Chem. Commun. 51 (2015), 8574–8583, 10.1039/C5CC01535A.
11. [11] Maquart, F.X., Pasco, S., Ramont, L., Hornebeck, W., Monboisse, J.C., An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity – implication in tumor invasion. Crit. Rev. Oncol. Hematol. 49 (2004), 199–202, 10.1016/j.critrevonc.2003.06.007.
12. [12] Robinson, L.R., Fitzgerald, N.C., Doughty, D.G., Dawes, N.C., Berge, C.A., Bissett, D.L., Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin 1. Int. J. Cosmet. Sci. 27 (2005), 155–160, 10.1111/j.1467-2494.2005.00261.x.
13. [13] Namjoshi, S., Caccetta, R., Benson, H.A.E., Skin peptides: biological activity and therapeutic opportunities. J. Pharm. Sci. 97 (2008), 2524–2542, 10.1002/jps.
14. [14] Zhang, L., Falla, T.J., Cosmeceuticals and peptides. Clin. Dermatol. 27 (2009), 485–494, 10.1016/j.clindermatol.2009.05.013.
15. [15] Karami, Z., Hamidi, M., Cubosomes: remarkable drug delivery potential. Drug Discov. Today 21 (2016), 789–801, 10.1016/j.drudis.2016.01.004.
16. [16] Garg, G., Saraf, S., Saraf, S., Cubosomes: an overview. Biol. Pharm. Bull. 30 (2007), 350–353.
17. [17] Gustafsson, J., Ljusberg-Wahren, H., Almgren, M., Larsson, K., Cubic lipid-water phase disperesed into submicron particles. Langmuir 12 (1996), 4611–4613, 10.1021/la960318y.
18. [18] Gustafsson, J., Ljusberg-Wahren, H., Almgren, M., Larsson, K., Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer. Langmuir 13 (1997), 6964–6971, 10.1021/la970566+.
19. [19] Chang, C.M., Bodmeier, R., Swelling of and drug release from monoglyceride-based drug delivery systems. J. Pharm. Sci. 86 (1997), 747–752, 10.1021/js960256w.
20. [20] Kwon, T.K., Kim, J.C., In vitro skin permeation of monoolein nanoparticles containing hydroxypropyl β-cyclodextrin/minoxidil complex. Int. J. Pharm. 392 (2010), 268–273, 10.1016/j.ijpharm.2010.03.049.
21. [21] Morsi, N.M., Abdelbary, G.A., Ahmed, M.A., Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. Eur. J. Pharm. Biopharm. 86 (2014), 178–189, 10.1016/j.ejpb.2013.04.018.
22. [22] Rattanapak, T., Birchall, J., Young, K., Ishii, M., Meglinski, I., Rades, T., Hook, S., Transcutaneous immunization using microneedles and cubosomes: mechanistic investigations using optical coherence tomography and two-photon microscopy. J. Control. Release 172 (2013), 894–903, 10.1016/j.jconrel.2013.08.018.
23. [23] Liu, Q., Dong, Y., Hanley, T.L., Boyd, B.J., Sensitivity of nanostructure in charged cubosomes to phase changes triggered by ionic species in solution. Langmuir 29 (2013), 14265–14273, 10.1021/la402426y.
24. [24] Angelov, B., Angelova, A., Filippov, S.K., Drechsler, M., Štěpánek, P., Lesieur, S., Multicompartment lipid cubic nanoparticles with high protein upload: millisecond dynamics of formation. ACS Nano 8 (2014), 5216–5226, 10.1021/nn5012946.
25. [25] Angelova, A., Angelov, B., Drechsler, M., Garamus, V.M., Lesieur, S., Protein entrapment in PEGylated lipid nanoparticles. Int. J. Pharm. 454 (2013), 625–632, 10.1016/j.ijpharm.2013.06.006.
26. [26] Rizwan, S.B., Assmus, D., Boehnke, A., Hanley, T., Boyd, B.J., Rades, T., Hook, S., Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. Eur. J. Pharm. Biopharm. 79 (2011), 15–22, 10.1016/j.ejpb.2010.12.034.
27. [27] Chemelli, A., Conde-Valentín, B., Uhlig, F., Glatter, O., Amino acid induced modification of self-assembled monoglyceride-based nanostructures. Langmuir, 0, 2015, 10.1021/acs.langmuir.5b02139 150915134554002.
28. [28] Barauskas, J., Johnsson, M., Joabsson, F., Cubic phase nanoparticles (cubosome): principles for controlling size. Struct. Stability Langmuir 21 (2005), 2569–2577, 10.1021/la047590p.
29. [29] Castelletto, V., Hamley, I.W., Whitehouse, C., Matts, P.J., Osborne, R., Baker, E.S., Self-assembly of palmitoyl lipopeptides used in skin care products. Langmuir 29 (2013), 9149–9155, 10.1021/la401771j.
30. [30] Boyd, B., Characterisation of drug release from cubosomes using the pressure ultrafiltration method. Int. J. Pharm. 260 (2003), 239–247, 10.1016/S0378-5173(03)00262-X.
31. [31] Clogston, J., Caffrey, M., Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids. J. Control. Release 107 (2005), 97–111, 10.1016/j.jconrel.2005.05.015.
32. [32] Nguyen, T.H., Hanley, T., Porter, C.J.H., Boyd, B.J., Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. J. Control. Release 153 (2011), 180–186, 10.1016/j.jconrel.2011.03.033.